[1]
Kumar, S.A. and C. V., R.C. 2022. Investigational synthetic neuroactive steroid zuranolone in treatment of major depressive disorder with peripartum onset. International Journal of Basic & Clinical Pharmacology. 11, 3 (Apr. 2022), 275–278. DOI:https://doi.org/10.18203/2319-2003.ijbcp20221045.